News

Bloomberg BusinessWeek rakes over charitable copay programs

Looming EU IDMP mandates are only part of the potential applications

The growing compliance requirements for distribution call for a streamlined approach

PhRMA-sponsored study outlines the economic effects of US-based operations

Practice Fusion taps into a 38-million-patient database

Few new treatments are available while antibiotic resistance is growing, says Pew Charitable Trust

Company pursues ‘bench to bedside’ commercialization services

Dispense As Written

Demand for cryogenic logistics propels business growth

Program seeks to improve care while reducing costs

Site opens up a Facebook-like “Pages” to vendors and medical organizations

Managed care organizations are adjusting rapidly to onslaught of specialty products

A raft of new therapies is generating renewed optimism for cancer care, but even as lower-cost biosimilars enter the market, cost is a crippling factor

Packaging designers continue the uphill battle for converting the US pharma industry to unit-dose, compliance-improving packaging

New IT data-science and visualization tools advance supply chain management

Policymakers look at alternative payment models in oncology

The SP channel continues to grow, with manufacturers looking for more control over access

Sharing clinical data—EvGen—will improve both drug development and health outcomes analysis

Pharma spends heavily to secure its supply chain, while politicians bring out the re-importation topic

Both clinical research and commercial analytics markets to be served by combination

More healthcare stakeholders line up against the industry

Better access to hospital systems is a goal; pharmaceutical business is fading

Integrating copay programs with multichannel marketing